Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07851610 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Right Heart and Lung Blood Flow During Exercise (RIGHT-NET 2.0)

Study acronym: RIGHT-NET 2
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
IRCCS SYNLAB SDN
6 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
RIGHT-NET 2.0 is a multicenter observational study with a retrospective-prospective design that builds on the original RIGHT-NET study. It aims to observe and document the functional status of the right heart-pulmonary circulation unit (RH-PCU) at rest and during exercise stress transthoracic echocardiography (ExTTE) in clinically stable patients referred to cardiology, internal medicine, echocardiography, and exercise testing laboratories. The study will also include healthy volunteers, individuals with cardiovascular risk factors but no overt disease, athletes undergoing sports eligibility evaluation, and healthy individuals living at high altitude. Patients will be classified according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The study plans to enroll at least 1000 additional subjects beyond the original RIGHT-NET cohort of 1000 participants, for a total anticipated enrollment of approximately 2000 subjects across 22 Italian and 16 international centers. Data will be collected through the REDCap electronic data capture platform in a pseudonymized format.
Trial Details
NCT Number NCT07851610
Lead Sponsor IRCCS SYNLAB SDN
Collaborators: University of Pisa, Institute of Clinical Physiology, CNR, Pisa, Fondazione IRCCS Policlinico San Matteo di Pavia, University of Milan, IRCCS Multimedica, University Of Perugia, ASST Grande Ospedale Metropolitano Niguarda, IRCCS Ospedale San Raffaele, University of Padova, Federico II University, University of Molise, University of Trieste, Medical University of Graz, Ohio State University, Jewish General Hospital (Montreal, Quebec, Canada), Universitat Politècnica de Catalunya, University Hospital Heidelberg, Institute of Family Medicine, University of Szeged, Hungary, Medical University of Lodz, Cardio-Thoracic-Vascular Department. University Hospital San Giovanni di Dio e Ruggi d'Aragona. Salerno, CRO "Centro Clinical Trials" IRCCS Ospedale Policlinico San Martino, Umberto I Hospital, Nocera Inferiore, Azienda Sanitaria Universitaria Friuli Centrale, Cardarelli Hospital, Azienda Ospedaliera dei Colli
Conditions
(from sponsor)		 Right Ventricular Dysfunction, Cardiopulmonary Diseases, Pulmonary Hypertension
Related terms Hypertension, Pulmonary, Pulmonary Heart Disease, Ventricular Dysfunction, Right
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov